Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing ...

Can the success of digital health coaching apps like Twine Health and WellDoc be ported over to the clinical trial space? According to Joris Van Dam, a strategic projects leader in pharmaceutical ...

Novartis hopes new data will open a $1 billion market opportunity for its radioligand therapy, Lutathera, as a first-line treatment. Friday, the company’s ambition received a boost from the phase 3 ...

A Novartis drug candidate for a rare kidney disease has preliminary data from a pivotal study suggesting it could be competitive with two available treatments, and the pharmaceutical giant is now ...

Novartis said its pill for rare kidney disease led to significantly lower protein levels among patients in a late-stage trial, setting up a potential regulatory filing next year. The Phase 3 study of ...

Exactly three years after an initial FDA green light for the third-line treatment of leukemia, Novartis’ Scemblix has won an accelerated approval to treat newly diagnosed patients. Tuesday, the FDA ...

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study. Before the end of the ...

Novartis said it plans to conduct a 440-person clinical trial to determine the effectiveness of hydroxychloroquine against COVID-19. The trial will be a randomized, double-blind placebo-controlled ...

ZURICH, Oct 6 (Reuters) - Swiss pharma group Novartis AG said on Monday it would work with Bristol-Myers Squibb Co to test the U.S. drugmaker's immuno-oncology drug Opdivo in combination with three of ...

When will Novartis and Google begin testing the autofocus contact lens they have been developing? Well, there’s still no clear date in sight. The pharmaceutical company announced late last week they ...

ROME, Oct 24 (Reuters) - The Italian health ministry said on Wednesday that it had imposed an immediate ban on the sale and use of four anti-influenza drugs produced by Swiss drugs group Novartis ...